| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 68 |
| 1 | OXALIPLATIN | 45 |
| 2 | CAPECITABINE | 38 |
| 3 | FLUOROURACIL | 31 |
| 4 | CISPLATIN | 21 |
| 5 | DEXAMETHASONE | 21 |
| 6 | DEXAMETHASONE 1.5 MG | 21 |
| 7 | PACLITAXEL | 17 |
| 8 | RAMUCIRUMAB | 17 |
| 9 | GRANISETRON HYDROCHLORIDE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVOLEUCOVORIN | 5 | 0.0048 |
| 1 | RAMUCIRUMAB | 17 | 0.0040 |
| 2 | DOSTARLIMAB | 1 | 0.0034 |
| 3 | NALDEMEDINE | 3 | 0.0030 |
| 4 | MANNITOL | 7 | 0.0021 |
| 5 | IRINOTECAN HYDROCHLORIDE | 10 | 0.0014 |
| 6 | GRANISETRON HYDROCHLORIDE | 10 | 0.0013 |
| 7 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 8 | OXALIPLATIN | 45 | 0.0010 |
| 9 | GRANISETRON | 7 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 17 | 0.0040 |
| 1 | Osmotic Diuretic [EPC] | 7 | 0.0020 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 70 | 0.0005 |
| 3 | Actinomycin [EPC] | 1 | 0.0005 |
| 4 | Platinum-based Drug [EPC] | 72 | 0.0004 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 69 | 0.0003 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 11 | 0.0003 |
| 7 | Anticholinergic [EPC] | 3 | 0.0002 |
| 8 | Microtubule Inhibitor [EPC] | 22 | 0.0002 |
| 9 | Immunoglobulin G [EPC] | 1 | 0.0002 |